BridgeBio Pharma BBIO) stock received a Perform rating from Oppenheimer on market challenges to its late-stage assets acoramidis and infigratinib. Read more here.
Hyderabad: He stands small but his achievements are indeed big. Despite locomotor disability and Achondroplasia, a genetic mutation, which restricted his height to just 3 feet and 9 inches, Bhavya ...